Bacterial

Items 351-400 of 1393

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. Bacterial Inhibitor

    Antibacterial agent 249 is a bacterial inhibitor that exhibits broad-spectrum antimicrobial properties. It effectively inhibits the growth of various pathogens including Aspergillus niger, Bacillus subtilis, Pseudomonas albicans, Escherichia coli, and Staphylococcus aureus. Additionally, it displays anti-inflammatory activity in vitro, highlighting its potential applications in the treatment of bacterial infections.
  2. Antibacterial Agent

    2',3'-Dehydrosalannol is a potent antibacterial agent that exhibits strong activity against a range of bacteria including Klebsiella pneumoniae ATCC 13883, Pseudomonas aeruginosa ATCC 27853, Staphylococcus aureus ATCC 25922, Escherichia coli ATCC 11775, and Enterococcus faecalis ATCC 10541. It displays minimum inhibitory concentration (MIC) values of 0.78, 1.56, 1.56, 6.25, and 25 μg/mL, respectively. This compound is valuable for research applications focusing on antibacterial drug development and microbiological studies.
  3. Antibacterial Agent

    Antibacterial Agent 38 is a novel antibacterial compound that selectively targets bacterial pathogens. It exhibits significant antimicrobial activity, making it suitable for research on bacterial infections and the development of new therapeutic strategies. This compound represents a promising tool for investigating the mechanisms of bacterial resistance and evaluating the efficacy of antimicrobial agents.
  4. Anti-Bacterial Agent

    Rhodirubin B is an anti-bacterial agent primarily targeting Gram-positive bacteria and exhibiting activity against Mycobacterium species. This compound has demonstrated the ability to enhance survival rates in mice inoculated with leukemia L-1210, indicating potential applications in cancer research and infectious disease studies. Rhodirubin B is valuable for investigating mechanisms of bacterial resistance and the interplay between infection and cancer.
  5. Bacterial Inhibitor

    Kipukasin D is a natural nucleoside derived from Aspergillus versicolor, exhibiting potent antibacterial activity. It operates primarily as a bacterial inhibitor, making it valuable for research involving bacterial infections and microbial resistance mechanisms. This compound is useful for studies in pharmacology, microbiology, and drug development focused on identifying new antimicrobial agents.
  6. Bacterial Inhibitor

    Antistaphylococcal agent 3 is a bacterial inhibitor that targets Staphylococcus species, disrupting their growth and proliferation. This compound exhibits potent antimicrobial activity, making it suitable for research applications focused on bacterial infection models and therapeutic development. Its efficacy against resistant strains renders it valuable for studies aimed at understanding staphylococcal pathogenesis and developing novel antibacterial strategies.
  7. Anti-Bacterial Agent

    Rhodirubin A is an anti-bacterial agent primarily targeting Gram-positive bacteria and demonstrating efficacy against Mycobacterium species. In addition to its antibacterial properties, Rhodirubin A has been shown to extend the survival time in mice models inoculated with leukemia L-1210. This compound is valuable in research applications focused on infection control and cancer biology.
  8. Bacterial Inhibitor

    DS-8587 is a novel fluoroquinolone designed as a bacterial inhibitor, demonstrating significant antibacterial activity against amoxicillin-resistant Bacillus strains. Its minimum inhibitory concentration (MIC) values outperform those of ciprofloxacin and levofloxacin, while exhibiting reduced susceptibility to efflux pump-mediated resistance mechanisms such as adeA/adeB/adeC and abeM. Additionally, DS-8587 has a lower single-step mutation frequency compared to ciprofloxacin, positioning it as a promising therapeutic candidate for the treatment of amoxicillin-resistant Bacillus infections.
  9. Bacterial Inhibitor

    Urechistachykinin I is a tachykinin-related peptide derived from echiuroid worms, primarily targeting bacterial pathogens. This compound exhibits significant antimicrobial activity while demonstrating no hemolytic effects, making it a valuable reagent for research into antimicrobial mechanisms and agents. Its unique properties make it suitable for studies investigating bacterial inhibition in various biological contexts.
  10. Antibacterial/Anti-inflammatory Agent

    Antibacterial Agent 115 is a potent antibacterial and anti-inflammatory compound. It demonstrates significant efficacy in inhibiting bacterial growth while simultaneously modulating inflammatory responses. This compound is suitable for research applications aimed at understanding bacterial resistance mechanisms and the development of novel therapeutic strategies for bacterial infections and related inflammatory conditions.
  11. Anti-bacterial Agent

    Antibacterial Agent 204 (Compd P2-56-3) is an anti-bacterial agent that exhibits enhanced Rifampin activity against Acinetobacter baumannii and Klebsiella pneumoniae. This compound disrupts the outer membrane of A. baumannii, which contributes to its antimicrobial efficacy. Antibacterial Agent 204 is applicable in research focused on developing novel treatments for infections caused by resistant bacterial strains.
  12. Antibacterial Agent

    Antibacterial agent 82 (compound 7p) functions as an antibacterial agent targeting bacterial growth and proliferation. It exhibits significant efficacy against a range of Gram-positive and Gram-negative bacteria, making it suitable for studies focused on antimicrobial resistance and infection control. This compound is ideal for use in pharmacological research, including the development of new antibacterial therapies and mechanisms underlying bacterial pathogenesis.
  13. Antibacterial Compound

    (6E,12E)-Tetradecadiene-8,10-diyne-1,3-diol is an antibacterial compound known for its effectiveness against methicillin-resistant Staphylococcus aureus (MRSA), exhibiting minimum inhibitory concentration (MIC) values of 4-32 μg/mL. Isolated from the roots of Atractylodes japonica, this compound serves as a valuable tool in the study of bacterial infections. Additionally, it functions as a click chemistry reagent due to its alkyne group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with azide-containing molecules.
  14. Antifouling/Antibacterial Agent

    Cochliomycin A is an antifouling and antibacterial agent derived from the Gorgonian-Derived Fungus Cochliobolus lunatus. It exhibits significant antifouling activity, with an EC50 of 1.2 μg/mL, effectively inhibiting barnacle larval settlement through stimulation of the NO/cGMP signaling pathway. Additionally, Cochliomycin A demonstrates moderate antibacterial efficacy against Staphylococcus aureus, making it valuable for research applications in marine biology and antimicrobial studies.
  15. Antibacterial Agent

    Trospectomycin dihydrochloride is an antibacterial agent targeting bacterial ribosome function. This compound demonstrates broad-spectrum activity against various gram-positive and gram-negative bacteria. Trospectomycin dihydrochloride is suitable for research applications involving the study of bacterial infections and the evaluation of antibiotic resistance mechanisms.
  16. Antibacterial Agent

    Furaltadone is a nitrofuran derivative that acts as an antibacterial agent primarily targeting gram-positive bacteria. It demonstrates both inhibitory and bactericidal effects against staphylococci in vitro. This compound is particularly relevant for research on bacterial infections, including those caused by Salmonella enteritidis in poultry, offering insights into its therapeutic potential in veterinary medicine.
  17. Antibacterial Agent

    Armeniaspirol C is a potent antibacterial agent that specifically targets Gram-positive bacteria. This compound demonstrates significant efficacy against multidrug-resistant strains, making it a valuable candidate for research into infections caused by resistant Gram-positive pathogens. Its unique mechanism of action positions Armeniaspirol C as a promising tool for the development of new antibacterial therapies.
  18. Bacterial Metabolite

    Aklaviketone is a bacterial metabolite derived from the strain S 383 of Streptomyces galilaeus. This compound plays a crucial role in the biosynthetic pathway of anthracycline antibiotics, contributing to their formation and activity. Aklaviketone is valuable for research applications focused on antibiotic synthesis and microbial metabolism.
  19. Antibacterial Agent

    Piperic acid is an antibacterial agent that exhibits natural antioxidant properties. It is recognized for its ability to inhibit bacterial growth, making it valuable for applications in food preservation and health-related research. Its utility in investigating antibacterial mechanisms further enhances its relevance in the study of microbial infections and therapeutic development.
  20. Antibacterial Agent

    16-Deethylindanomycin is an antibiotic derived from Streptomyces setonii, targeting bacterial cell function. It demonstrates potent antimicrobial activity against gram-positive bacteria, including Staphylococcus spp. and Streptococcus, with a minimum inhibitory concentration (MIC) of 2-4 µg/mL. Additionally, 16-Deethylindanomycin exhibits anticoccidial properties against Eimeria tenella, making it valuable for research in infectious diseases and veterinary applications.
  21. Antibacterial Agent

    Antibacterial Agent 287, a derivative of Deoxynybomycin, functions primarily as an antibacterial agent. It demonstrates potent antibacterial activity against various Gram-negative bacteria, exhibiting minimum inhibitory concentrations (MICs) of 0.5 μg/mL for wild-type Staphylococcus aureus, 0.5 μg/mL for wild-type Escherichia coli, and 0.06 μg/mL for E. coli ΔtolC. This compound is particularly relevant for research into multidrug-resistant (MDR) bacterial infections.
  22. Antibacterial Agent

    Lysozyme from chicken egg white is an antibacterial enzyme that primarily targets and lyses gram-positive bacteria. Its bactericidal activity makes it useful in various research applications, including studies on HIV infection and the mechanisms underlying pulmonary emphysema. This enzyme plays a significant role in investigating bacterial pathogenesis and serves as a model for understanding immune responses.
  23. Bacterial Inhibitor

    (Z)-Ligustilide acts as a bacterial inhibitor with demonstrated antimicrobial and antifungal properties. Extracted from Ligusticum chuanxiong Hort, it has shown an average antifungal score of 5.6. This compound inhibits the expression of FATP5 and DGAT, thereby reducing fatty acid uptake and esterification, positioning it as a potential therapeutic agent for nonalcoholic fatty liver disease (NAFLD). Additionally, (Z)-Ligustilide is involved in reactivating ERα and exhibits epigenetic regulatory functions, making it relevant for research into tamoxifen-resistant breast cancer.
  24. Antibacterial agent

    S-Methyl thiomethanesulfonate (MMTS) is a sulfur-containing compound recognized for its antibacterial properties. It exerts its biological activity through the inhibition of microbial growth, making it valuable for studies focused on bacterial infections and plant-pathogen interactions. MMTS serves as a key reagent in research involving antimicrobial screening and the development of new antibacterial agents.
  25. Antibacterial Agent

    Isoforsythiaside is a phenylethanoid glycoside known for its antioxidant and antibacterial properties. It exhibits minimum inhibitory concentrations (MICs) of 40.83 μg/mL against Escherichia coli and Pseudomonas aeruginosa, and 81.66 μg/mL against Staphylococcus aureus. This compound is useful in research applications focusing on antibacterial agents and may offer insights into microbial resistance mechanisms.
  26. Antibacterial Agent

    Adamantane-carboxylic acid is an antibacterial agent that demonstrates inhibitory activity against various microorganisms, including both Gram-positive and select Gram-negative bacteria. This compound operates by altering the permeability of the bacterial cell membrane and can form a 1-monoacylglycerol derivative through a direct reaction with glycidol. It serves as a valuable reagent in research aimed at developing antibacterial agents, particularly in the food and cosmetic industries, to mitigate harmful microbial flora and enhance product shelf life.
  27. Bacterial Inhibitor

    Roseoflavin is a bacterial inhibitor, functioning as an antimetabolite analog of riboflavin and flavin mononucleotide. This natural pigment, originally extracted from Streptomyces davawensis, exhibits potent antimicrobial properties. It is commonly utilized in research applications aimed at studying bacterial metabolism and the mechanisms of antibiotic resistance.
  28. Antibacterial Agent

    D-Cysteine is the D-isomer of cysteine, known for its antibacterial properties. It exhibits inhibitory activity against key pathogens such as Escherichia coli, Streptococcus mutans, and Streptococcus sanguinis. Additionally, D-Cysteine plays a regulatory role in the proliferation of neural progenitor cells, making it valuable in various research applications focused on antibacterial mechanisms and neurobiology. The no-observed-adverse-effect level in rat studies is reported to be less than 500 mg/kg/day.
  29. Bacterial Inhibitor

    Poly-L-lysine hydrochloride is a cationic polymer that functions as a bacterial inhibitor by enhancing cell adhesion through electrostatic interactions with negatively charged cell membranes. It promotes liquid-liquid phase separation (LLPS) at low concentrations while inhibiting LLPS at elevated concentrations, making it a versatile tool for cell culture applications. This reagent is particularly useful in studies involving bacterial attachment mechanisms and cell substrate interactions.
  30. Antibacterial Agent

    Ceftaroline is an N-phosphono-type cephalosporin with potent antibacterial properties. It exhibits activity against a broad spectrum of gram-positive and gram-negative bacteria, making it a valuable agent for research in microbial susceptibility and resistance. Ceftaroline is primarily utilized in studies aimed at developing new therapeutic strategies to combat bacterial infections.
  31. Bacterial Riboflavin Riboswitches Inhibitor

    Ribocil-C is a potent inhibitor of bacterial riboflavin riboswitches, targeting their regulatory mechanism to disrupt riboflavin biosynthesis. This compound exhibits a high degree of selectivity and is valuable for studying riboswitch function and its role in bacterial gene regulation. Ribocil-C is applicable in research focusing on microbial metabolism and the development of antibacterial strategies.
  32. Antibacterial Agent

    Temocillin disodium is a 6-α-methoxy penicillin that functions as an antibacterial agent. It exhibits activity against a range of gram-negative bacteria, making it valuable in research focused on infectious diseases and antibiotic resistance. Temocillin disodium can be utilized in studies involving microbial susceptibility and therapeutic interventions for bacterial infections.
  33. Bacterial Collagenase Substrate

    FA-Leu-Gly-Pro-Ala-OH is a furylacryloyl-terminal tetrapeptide that acts as a substrate specifically for bacterial collagenase and spirochete metalloendopeptidase. It is selectively hydrolyzed at the Leu-Gly bond by spirochete collagenase, making it useful for studying peptide bond hydrolysis kinetics. This reagent can also be employed in detecting collagenase-mediated cleavage reactions using turbidimetry through absorbance reduction, providing valuable insights into enzyme activity and specificity.
  34. Antibacterial agent

    2-Hydroxycinnamic acid functions primarily as an antibacterial agent, exhibiting potent antimicrobial properties. This phenolic acid demonstrates efficacy against Staphylococcus aureus and remains unaffected by common drug resistance mechanisms. Additionally, it has shown inhibitory effects on HIV/SARS-CoV S pseudovirus, with an IC50 of 0.3 mM. Furthermore, 2-Hydroxycinnamic acid also possesses neuroprotective and antitumor activities, making it valuable for a variety of research applications in microbiology and oncology.
  35. Antibacterial Agent

    MRL-494 hydrochloride is an antibacterial agent that functions as an inhibitor of the β-barrel assembly machine A (BamA), effectively circumventing efflux and the outer membrane permeability barrier. It exhibits significant antibacterial activity against Gram-positive bacteria, with a minimum inhibitory concentration (MIC) of 12.5 μM for Staphylococcus aureus COL, and against Gram-negative bacteria, with an MIC of 25 μM for Escherichia coli JCM158. This compound is suitable for research applications focused on combating bacterial infections and studying membrane protein assembly.
  36. Antibacterial Agents

    Polyaniline is a conductive polymer primarily known for its ability to act as an antibacterial agent. Its unique electrical properties and structure enhance its interaction with microbial cells, leading to effective inhibition of growth. This compound is particularly useful in the development of antimicrobial coatings and materials for biomedical applications, making it an important resource for research in infection control and materials science.
  37. Antibacterial Agent

    4aα,7α,7aα-Nepetalactone is an antibacterial agent that demonstrates activity against a range of pathogenic bacteria. It effectively inhibits the growth of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella typhi, and Enterococcus faecalis. This compound is valuable for research applications focused on the study of antibacterial mechanisms and the development of new antimicrobial therapies.
  38. Bacterial Inhibitor

    Lymecycline is a tetracycline derivative known for its mechanism as a bacterial inhibitor. It exhibits broad-spectrum antibacterial activity, making it effective against a variety of bacterial infections. Additionally, Lymecycline possesses anti-inflammatory properties, which may be beneficial in treating conditions where inflammation plays a significant role. Its applications in research include studying bacterial resistance mechanisms and exploring its therapeutic potential in inflammatory diseases.
  39. Bacterial Inhibitor

    Procyanidin A2 is a flavonoid with documented antibacterial properties. It exhibits significant antimicrobial activity, making it a valuable compound for research into bacterial inhibition and potential therapeutic applications. Additionally, Procyanidin A2 possesses antioxidant and anti-inflammatory effects, further supporting its relevance in studies focused on cancer and inflammatory diseases.
  40. Bacterial Inhibitor

    Skullcapflavone II is a flavonoid derived from Scutellaria baicalensis that primarily targets bacterial pathogens. It exhibits significant anti-inflammatory and antimicrobial properties, demonstrating potent efficacy against Mycobacterium aurum and Mycobacterium bovis BCG. This compound is valuable for research focused on osteoclast differentiation, survival, and function as well as the development of novel antibacterial therapies.
  41. Antibacterial Agent

    Sapienic acid sodium is a sodium salt of a naturally occurring fatty acid that exhibits antibacterial properties. It demonstrates variable antimicrobial activity against both Gram-positive and Gram-negative bacteria, particularly those associated with skin and oral mucosa. Notably, it is effective against Streptococcus sanguinis, Streptococcus mitis, and Fusobacterium nucleatum, with minimum bactericidal concentration (MBC) values of 31.3 μg/mL, 375.0 μg/mL, and 93.8 μg/mL, respectively. This reagent is valuable for research applications focused on bacterial infections and skin health.
  42. Bacterial Inhibitor

    Acetylalkannin is an isohexenylnaphthazarin pigment derived from Arnebia euchroma, primarily known for its bacterial inhibitory properties. This compound exhibits significant antimicrobial and cytotoxic activities, making it valuable for research in antibacterial drug development and cell viability studies. Its unique structure and biological efficacy provide a useful tool for investigating microbial interactions and potential therapeutic applications.
  43. Antibacterial Agent

    α-Pyridone is an antibacterial agent that functions as a versatile scaffold in biochemical research. It is utilized to synthesize a range of bioactive compounds, contributing to the development of new therapeutic agents. Its unique structural properties make it suitable for investigations aimed at understanding bacterial inhibition mechanisms and exploring novel antibacterial treatments.
  44. Anti-Bacterial Agent

    Chalcone is a naturally occurring compound primarily recognized for its anti-bacterial activity. It acts as a precursor for the synthesis of various chalcone derivatives, which exhibit a broad range of biological and pharmacological effects, including anti-inflammatory, antioxidative, anticancer, and anti-parasitic properties. This compound serves as a valuable research tool in exploring therapeutic avenues for bacterial infections and related conditions.
  45. Antibacterial Peptide

    Elf18 is a peptide fragment derived from the bacterial translation elongation factor Tu (EF-Tu), functioning primarily as an antibacterial agent. It is recognized by plant pattern recognition receptors, triggering an immune response that enhances plant resistance to various pathogens. This peptide is valuable for research applications focused on understanding and improving plant immune responses.
  46. Bacterial Inhibitor

    4-Hydroxycoumarin is a versatile coumarin derivative that acts as a bacterial inhibitor. It demonstrates both electrophilic and nucleophilic properties, making it a valuable scaffold in organic synthesis. This compound exhibits significant biological activities, including anti-inflammatory, antibacterial, and anti-tumor effects, and has been utilized in research focusing on HIV protease and tyrosine kinase inhibition. Its multifaceted applications make it an important reagent in chemical and biological research.
  47. Bacterial Inhibitor

    Furanone C-30 is a potent quorum sensing inhibitor that targets bacterial communication systems. It effectively disrupts biofilm formation in Streptococcus mutans, including its luxS mutant strain. This compound is valuable for research applications focused on bacterial pathogenesis and biofilm-related studies, providing insights into microbial interactions and potential therapeutic strategies against bacterial infections.
  48. Antibacterial Agent

    1-Hydroxyphenazine is an antibacterial agent that targets α-Amylase with an IC50 value of 3.1 μg/mL. This compound demonstrates significant anticancer and anti-inflammatory activities, effectively reducing proliferation in A549, 1321N1, and RAW264.7 cell lines. Additionally, 1-Hydroxyphenazine exhibits notable antifungal and antibacterial properties against pathogens such as Candida albicans, Aspergillus fumigatus, Escherichia coli, and Xanthomonas campestris, making it a valuable reagent for various biological research applications.
  49. Bacterial Inhibitor/Anti-inflammatory Agent

    Cyclo(L-Pro-L-Val) is a peptide-based compound that functions as a bacterial inhibitor and anti-inflammatory agent. It exhibits antimicrobial activity against plant pathogens, such as R. fascians, and demonstrates significant inhibition of critical signaling molecules like IKKα, IKKβ, NF-κB, iNOS, and COX-2, contributing to its anti-inflammatory properties. This compound is valuable for research applications in developing biopesticides and investigating inflammation-related diseases.
  50. Antibacterial Agent

    Diazaborine is an inhibitor of enoyl-acyl carrier protein (enoyl ACP) with an NAD+-dependent mechanism of action. This compound demonstrates significant antibacterial activity, exhibiting minimum inhibitory concentrations (MIC) of 25 µg/mL against Escherichia coli and 3.12 µg/mL against Klebsiella pneumoniae. Diazaborine serves as a valuable tool for research into antimicrobial resistance and the development of new antibacterial therapies.

Items 351-400 of 1393

Page
per page
Set Descending Direction